Femasys Inc.
10/17/2025 | Press release | Distributed by Public on 10/17/2025 15:16
Management Change/Compensation (Form 8-K)
| Item 5.02. |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
|
On October 13, 2025, Daniel Currie, Chief Operating Officer of Femasys Inc. (the "Company") informed the Company of his decision to retire from the Company, effective as of December 15, 2025. Mr. Currie will remain in his current role with the Company until his departure.
Mr. Currie's decision to retire follows more than 20 years of dedicated service, having joined the Company in March 2004, and is based on personal health considerations, a desire to focus on family and the next chapter of his life.
In connection with his planned retirement, on October 16, 2025, the Company and Daniel Currie entered into a Separation and General Release Agreement (the "Separation Agreement").
Under the terms of the Separation Agreement:
|
|
• |
Any outstanding equity awards will be treated as follows: unvested stock options will vest through the retirement date.
|
|
|
• |
Health benefits will continue under COBRA through December 31, 2026, with Company contributions consistent with current coverage levels.
|
|
|
• |
The Separation Agreement includes a general release of claims, as well as non-competition, non-solicitation, and confidentiality covenants customary for such agreements.
|
The Company and Board of Directors extend their sincere appreciation to Mr. Currie for his more than 20 years of leadership and service and wish him the very best in his retirement.
Femasys Inc. published this content on October 17, 2025, and is solely responsible for the information contained herein. Distributed via EDGAR on October 17, 2025 at 21:16 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]